Pub Date : 2025-12-08DOI: 10.1016/j.exger.2025.112989
Kaixin Zhang , Xiaowei Zheng , Tao Ma
Background and objectives
Little is known about the association between changes in sarcopenia status with cardiovascular disease (CVD) and all-cause mortality. We aimed to evaluate the associations between sarcopenia status changes and incident CVD and mortality in a large prospective cohort of middle-aged and older adults.
Methods
A total of 7257 participants from the China Health and Retirement Longitudinal Study 2011 were included in analyses. Sarcopenia status was defined according to the Asian Working Group for Sarcopenia 2019 (AWGS 2019) criteria. Cox proportional hazards regression models were used to examine the association of changes in sarcopenia status (never, onset, remitted, and persistent) with CVD (stroke or cardiac events) and all-cause mortality.
Results
During a maximum follow-up period of 2 years, a total of 722 (9.95 %) respondents experienced CVD (303 stroke and 456 cardiac events), and 292 (4.02 %) deaths were identified. Compared to participants without any sarcopenia, those in the improved and persistent sarcopenia had an increased risk of CVD, with multiple-adjusted hazard ratios (95 % confidence intervals) of 1.37 (1.04–1.80) and 1.32 (1.03–1.69), respectively. Individuals with improved and persistent sarcopenia also had higher risk of stroke and cardiac events. Among participants with baseline possible sarcopenia, those who recovered to a non-sarcopenia status had a significantly lower risk of new-onset CVD and stroke, compared to those who remained in the possible sarcopenia status.
Conclusion
Changes in sarcopenia status are associated with varying risks of new-onset CVD risk and all-cause mortality. Monitoring long-term changes in the sarcopenia should prioritize CVD prevention strategies.
{"title":"Longitudinal changes of sarcopenia status and risks of cardiovascular disease and all-cause mortality","authors":"Kaixin Zhang , Xiaowei Zheng , Tao Ma","doi":"10.1016/j.exger.2025.112989","DOIUrl":"10.1016/j.exger.2025.112989","url":null,"abstract":"<div><h3>Background and objectives</h3><div>Little is known about the association between changes in sarcopenia status with cardiovascular disease (CVD) and all-cause mortality. We aimed to evaluate the associations between sarcopenia status changes and incident CVD and mortality in a large prospective cohort of middle-aged and older adults.</div></div><div><h3>Methods</h3><div>A total of 7257 participants from the China Health and Retirement Longitudinal Study 2011 were included in analyses. Sarcopenia status was defined according to the Asian Working Group for Sarcopenia 2019 (AWGS 2019) criteria. Cox proportional hazards regression models were used to examine the association of changes in sarcopenia status (never, onset, remitted, and persistent) with CVD (stroke or cardiac events) and all-cause mortality.</div></div><div><h3>Results</h3><div>During a maximum follow-up period of 2 years, a total of 722 (9.95 %) respondents experienced CVD (303 stroke and 456 cardiac events), and 292 (4.02 %) deaths were identified. Compared to participants without any sarcopenia, those in the improved and persistent sarcopenia had an increased risk of CVD, with multiple-adjusted hazard ratios (95 % confidence intervals) of 1.37 (1.04–1.80) and 1.32 (1.03–1.69), respectively. Individuals with improved and persistent sarcopenia also had higher risk of stroke and cardiac events. Among participants with baseline possible sarcopenia, those who recovered to a non-sarcopenia status had a significantly lower risk of new-onset CVD and stroke, compared to those who remained in the possible sarcopenia status.</div></div><div><h3>Conclusion</h3><div>Changes in sarcopenia status are associated with varying risks of new-onset CVD risk and all-cause mortality. Monitoring long-term changes in the sarcopenia should prioritize CVD prevention strategies.</div></div>","PeriodicalId":94003,"journal":{"name":"Experimental gerontology","volume":"213 ","pages":"Article 112989"},"PeriodicalIF":4.3,"publicationDate":"2025-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145727422","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-08DOI: 10.1016/j.exger.2025.112988
Belia Schuurman , Jolanda Lindenberg , Tineke A. Abma , Wilco P. Achterberg
This study presents the first baseline analysis of the Dutch Age Implicit Association Test (IAT) data, examining both implicit and explicit ageism measures in the Netherlands. Analyzing data from 8680 participants over a range of 12 years, we investigated implicit ageism scores, their association with explicit ageism measures, and associations with demographic characteristics. Results position the Netherlands in the international midfield for implicit ageism. Significant gender differences emerged, with men showing higher implicit ageism scores than women. We found no significant relationship between age and implicit ageism. The study revealed small to moderate yet significant correlations between implicit and explicit ageism measures, suggesting these are subtly related yet distinct constructs. These findings contribute to the international comparative literature on ageism by establishing a Dutch baseline and emphasize the need for further research into the association between implicit and explicit ageism. To tackle the prevalence and consequences of ageism in our social lives and institutions, the mechanisms underlying age-related biases across different contexts need to be investigated further.
{"title":"A subtle association raising bigger questions: Implicit and explicit ageism in the Dutch age IAT","authors":"Belia Schuurman , Jolanda Lindenberg , Tineke A. Abma , Wilco P. Achterberg","doi":"10.1016/j.exger.2025.112988","DOIUrl":"10.1016/j.exger.2025.112988","url":null,"abstract":"<div><div>This study presents the first baseline analysis of the Dutch Age Implicit Association Test (IAT) data, examining both implicit and explicit ageism measures in the Netherlands. Analyzing data from 8680 participants over a range of 12 years, we investigated implicit ageism scores, their association with explicit ageism measures, and associations with demographic characteristics. Results position the Netherlands in the international midfield for implicit ageism. Significant gender differences emerged, with men showing higher implicit ageism scores than women. We found no significant relationship between age and implicit ageism. The study revealed small to moderate yet significant correlations between implicit and explicit ageism measures, suggesting these are subtly related yet distinct constructs. These findings contribute to the international comparative literature on ageism by establishing a Dutch baseline and emphasize the need for further research into the association between implicit and explicit ageism. To tackle the prevalence and consequences of ageism in our social lives and institutions, the mechanisms underlying age-related biases across different contexts need to be investigated further.</div></div>","PeriodicalId":94003,"journal":{"name":"Experimental gerontology","volume":"213 ","pages":"Article 112988"},"PeriodicalIF":4.3,"publicationDate":"2025-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145727484","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-05DOI: 10.1016/j.exger.2025.112987
Xiya Wang , Bowen Zhang , Ying Chen , Xinzhen Gao , Yongshen Bai , Shuxing Wei , Shubin Guo , Xue Mei
Background
Sepsis-induced acute respiratory distress syndrome (SI-ARDS) is associated with high mortality rates, necessitating early risk stratification. This study aimed to develop and validate a radiomics-based nomogram integrating computed tomography (CT) features and clinical parameters to predict 28-day mortality in older patients with SI-ARDS.
Methods
In this retrospective cohort study, 302 older patients (≥60 years) diagnosed with SI-ARDS between January 2019 and December 2023 were enrolled. Radiomic features were extracted from admission chest CT images. Patients were randomly allocated to training (n = 242) and validation (n = 60) cohorts. Three predictive models—radiomic, clinical, and combined—were constructed using Maximum Relevance Minimum Redundancy (MRMR) algorithm and Least Absolute Shrinkage and Selection Operator (LASSO) regression. Model performance was assessed using the concordance index (C-index), calibration curves, and decision curve analysis. A nomogram was developed based on the optimal model for clinical application.
Results
The fusion model achieved superior discrimination compared with the radiomic model, clinical model, and Sequential Organ Failure Assessment score in both cohorts (C-index: training, 0.850 vs. 0.798, 0.781, and 0.654; validation, 0.839 vs. 0.768, 0.779, and 0.696; all p < 0.001). The model demonstrated excellent calibration and provided greater net clinical benefit across threshold probabilities of 10 %–90 %. Risk stratification using the nomogram identified distinct prognostic groups with significantly different 28-day survival (log-rank p < 0.001).
Conclusion
The nomogram developed from the fusion model demonstrated superior predictive performance for 28-day mortality in older patients with SI-ARDS compared to conventional scoring systems, though multicenter validation is required to confirm clinical utility.
{"title":"Prognostic assessment of sepsis-induced acute respiratory distress syndrome in older patients using clinical and CT-based radiomic features","authors":"Xiya Wang , Bowen Zhang , Ying Chen , Xinzhen Gao , Yongshen Bai , Shuxing Wei , Shubin Guo , Xue Mei","doi":"10.1016/j.exger.2025.112987","DOIUrl":"10.1016/j.exger.2025.112987","url":null,"abstract":"<div><h3>Background</h3><div>Sepsis-induced acute respiratory distress syndrome (SI-ARDS) is associated with high mortality rates, necessitating early risk stratification. This study aimed to develop and validate a radiomics-based nomogram integrating computed tomography (CT) features and clinical parameters to predict 28-day mortality in older patients with SI-ARDS.</div></div><div><h3>Methods</h3><div>In this retrospective cohort study, 302 older patients (≥60 years) diagnosed with SI-ARDS between January 2019 and December 2023 were enrolled. Radiomic features were extracted from admission chest CT images. Patients were randomly allocated to training (n = 242) and validation (n = 60) cohorts. Three predictive models—radiomic, clinical, and combined—were constructed using Maximum Relevance Minimum Redundancy (MRMR) algorithm and Least Absolute Shrinkage and Selection Operator (LASSO) regression. Model performance was assessed using the concordance index (C-index), calibration curves, and decision curve analysis. A nomogram was developed based on the optimal model for clinical application.</div></div><div><h3>Results</h3><div>The fusion model achieved superior discrimination compared with the radiomic model, clinical model, and Sequential Organ Failure Assessment score in both cohorts (C-index: training, 0.850 vs. 0.798, 0.781, and 0.654; validation, 0.839 vs. 0.768, 0.779, and 0.696; all <em>p</em> < 0.001). The model demonstrated excellent calibration and provided greater net clinical benefit across threshold probabilities of 10 %–90 %. Risk stratification using the nomogram identified distinct prognostic groups with significantly different 28-day survival (log-rank <em>p</em> < 0.001).</div></div><div><h3>Conclusion</h3><div>The nomogram developed from the fusion model demonstrated superior predictive performance for 28-day mortality in older patients with SI-ARDS compared to conventional scoring systems, though multicenter validation is required to confirm clinical utility.</div></div>","PeriodicalId":94003,"journal":{"name":"Experimental gerontology","volume":"213 ","pages":"Article 112987"},"PeriodicalIF":4.3,"publicationDate":"2025-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145703549","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The copper-to‑zinc (Cu/Zn) ratio is linked to inflammation and aging, but longitudinal evidence for sarcopenia remains limited. We examined associations of serum copper (Cu), zinc (Zn), and Cu/Zn ratio with adverse health outcomes and sarcopenia.
Methods
Cu, Zn, and the Cu/Zn ratio were analyzed as continuous variables and by tertiles. The study included (1) a 5-year survival analysis assessing associations with adverse outcomes (falls, hospital admissions, emergency department visits, mortality, and a composite outcome); and (2) cross-sectional and 3-year longitudinal analysis examining their associations with prevalent and incident sarcopenia. Sarcopenia was defined based on the Asian Working Group for Sarcopenia 2019 criteria.
Results
Over five years, 357 of 2015 participants experienced adverse events; 311 of 1474 non-sarcopenic participants developed incident sarcopenia over three years. Each standard deviation increase in the Cu/Zn ratio was associated with higher risks of adverse outcomes (aHR 1.18, 95 % CI 1.04–1.33, p = 0.008), hospitalization (aHR 1.23, 95 % CI 1.02–1.49, p = 0.030), mortality (aHR 1.50, 95 % CI 1.06–2.13, p = 0.021), and incident sarcopenia (aOR 1.39, 95 % CI 1.13–1.73, p < 0.001). Higher Cu levels predicted low muscle mass (aOR 1.18, 95 % CI 1.05–1.33, p = 0.005), while higher Zn levels were protective against muscle weakness (aOR 0.84, 95 % CI 0.73–0.97, p = 0.015). Importantly, the association between the Cu/Zn ratio and incident sarcopenia remained significant after additional adjustment for cardiometabolic risk factors and inflammatory biomarkers.
Conclusions
Elevated serum Cu/Zn ratio predicts adverse outcomes and sarcopenia, highlighting its value as a biomarker for clinical risk in older adults.
{"title":"Copper-to-zinc ratio predicts incident sarcopenia and adverse health outcomes: Results from I-Lan Longitudinal Aging Study","authors":"Kuan-Yu Peng , Wei-Ju Lee , Chih-Kuang Liang , Li-Ning Peng , Ming-Hsien Lin , Ching-Hui Loh , Fei-Yuan Hsiao , Liang-Kung Chen","doi":"10.1016/j.exger.2025.112984","DOIUrl":"10.1016/j.exger.2025.112984","url":null,"abstract":"<div><h3>Introduction</h3><div>The copper-to‑zinc (Cu/Zn) ratio is linked to inflammation and aging, but longitudinal evidence for sarcopenia remains limited. We examined associations of serum copper (Cu), zinc (Zn), and Cu/Zn ratio with adverse health outcomes and sarcopenia.</div></div><div><h3>Methods</h3><div>Cu, Zn, and the Cu/Zn ratio were analyzed as continuous variables and by tertiles. The study included (1) a 5-year survival analysis assessing associations with adverse outcomes (falls, hospital admissions, emergency department visits, mortality, and a composite outcome); and (2) cross-sectional and 3-year longitudinal analysis examining their associations with prevalent and incident sarcopenia. Sarcopenia was defined based on the Asian Working Group for Sarcopenia 2019 criteria.</div></div><div><h3>Results</h3><div>Over five years, 357 of 2015 participants experienced adverse events; 311 of 1474 non-sarcopenic participants developed incident sarcopenia over three years. Each standard deviation increase in the Cu/Zn ratio was associated with higher risks of adverse outcomes (aHR 1.18, 95 % CI 1.04–1.33, <em>p</em> = 0.008), hospitalization (aHR 1.23, 95 % CI 1.02–1.49, <em>p</em> = 0.030), mortality (aHR 1.50, 95 % CI 1.06–2.13, <em>p</em> = 0.021), and incident sarcopenia (aOR 1.39, 95 % CI 1.13–1.73, <em>p</em> < 0.001). Higher Cu levels predicted low muscle mass (aOR 1.18, 95 % CI 1.05–1.33, <em>p</em> = 0.005), while higher Zn levels were protective against muscle weakness (aOR 0.84, 95 % CI 0.73–0.97, <em>p</em> = 0.015). Importantly, the association between the Cu/Zn ratio and incident sarcopenia remained significant after additional adjustment for cardiometabolic risk factors and inflammatory biomarkers.</div></div><div><h3>Conclusions</h3><div>Elevated serum Cu/Zn ratio predicts adverse outcomes and sarcopenia, highlighting its value as a biomarker for clinical risk in older adults.</div></div>","PeriodicalId":94003,"journal":{"name":"Experimental gerontology","volume":"213 ","pages":"Article 112984"},"PeriodicalIF":4.3,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145673213","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Understanding the dynamics of successful aging in India is crucial, especially in the context of a rising aging population. India, being home to one of the largest internal migrant population in the world, presents a unique context to examine how migration influences aging outcomes. This study investigates disparities in successful aging outcomes between migrant and non-migrant populations in India. Utilizing the Longitudinal Aging Study in India data (n = 23,690), it focuses on the impact of migration status, regional variations, and early life socio-economic and health conditions on aging. Logistic regression, propensity score matching and Blinder-Oaxaca decomposition are employed to explore the association between migration and successful aging. Results reveal significant disparities, with migrants less likely to achieve successful aging, particularly those from lower socio-economic backgrounds. Significant regional disparities and varied childhood socio-economic and health effects highlight the complex interplay between migration and socio-economic status in shaping successful aging trajectories in India. This study provides the first nationally representative evidence from India linking migration and aging, grounded in the Cumulative Inequality framework. The findings emphasize the need for migrant-inclusive aging and health policies, particularly improving portability of social protection, strengthening community-based care, and addressing gendered vulnerabilities to promote equitable and successful aging.
{"title":"Life after migration: A comparative study on successful aging in India","authors":"Bittu Mandal , Kalandi Charan Pradhan , Arun Balachandran","doi":"10.1016/j.exger.2025.112966","DOIUrl":"10.1016/j.exger.2025.112966","url":null,"abstract":"<div><div>Understanding the dynamics of successful aging in India is crucial, especially in the context of a rising aging population. India, being home to one of the largest internal migrant population in the world, presents a unique context to examine how migration influences aging outcomes. This study investigates disparities in successful aging outcomes between migrant and non-migrant populations in India. Utilizing the Longitudinal Aging Study in India data (<em>n</em> = 23,690), it focuses on the impact of migration status, regional variations, and early life socio-economic and health conditions on aging. Logistic regression, propensity score matching and Blinder-Oaxaca decomposition are employed to explore the association between migration and successful aging. Results reveal significant disparities, with migrants less likely to achieve successful aging, particularly those from lower socio-economic backgrounds. Significant regional disparities and varied childhood socio-economic and health effects highlight the complex interplay between migration and socio-economic status in shaping successful aging trajectories in India. This study provides the first nationally representative evidence from India linking migration and aging, grounded in the Cumulative Inequality framework. The findings emphasize the need for migrant-inclusive aging and health policies, particularly improving portability of social protection, strengthening community-based care, and addressing gendered vulnerabilities to promote equitable and successful aging.</div></div>","PeriodicalId":94003,"journal":{"name":"Experimental gerontology","volume":"212 ","pages":"Article 112966"},"PeriodicalIF":4.3,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145531071","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01DOI: 10.1016/j.exger.2025.112975
Pei-Hao Chen , Sang-I Lin , Ying-Yi Liao , Gwo-Chi Hu , Fang-Yu Cheng
Background
Mobility impairments such as slowed gait and diminished functional capacity are increasingly recognized as early indicators of neurodegenerative processes in aging, including Alzheimer's disease. While cerebrospinal fluid and imaging biomarkers have shown links to physical decline, blood-based biomarkers offer a less invasive and more scalable alternative. However, their associations with physical performance across different stages of cognitive aging remain insufficiently explored. This study aimed to examine the cross-sectional associations between plasma amyloid beta 42 and total tau levels and physical function in older adults with normal cognition, motoric cognitive risk syndrome, and mild Alzheimer's disease.
Methods
A total of 159 community-dwelling older adults were enrolled and categorized into three cognitive groups. Plasma biomarker levels were measured using immunomagnetic reduction assays. Physical function was assessed using gait speed, Timed Up and Go, tandem stance, and dual-task walking. Generalized linear models were applied to assess associations between biomarkers and performance within each group.
Results
Higher plasma amyloid beta 42 levels were significantly associated with poorer Timed Up and Go performance in the full sample and in those with motoric cognitive risk syndrome. Unexpectedly, higher plasma total tau levels were positively associated with gait speed in the motoric cognitive risk group. No significant associations were observed for balance or dual-task performance.
Conclusion
Plasma biomarkers may reflect stage-specific mobility changes in aging populations. Their integration with performance-based tests may support early identification of functional decline and guide timely interventions.
{"title":"Plasma Alzheimer's biomarkers and physical functions in aging adults with and without motoric cognitive risk syndrome","authors":"Pei-Hao Chen , Sang-I Lin , Ying-Yi Liao , Gwo-Chi Hu , Fang-Yu Cheng","doi":"10.1016/j.exger.2025.112975","DOIUrl":"10.1016/j.exger.2025.112975","url":null,"abstract":"<div><h3>Background</h3><div>Mobility impairments such as slowed gait and diminished functional capacity are increasingly recognized as early indicators of neurodegenerative processes in aging, including Alzheimer's disease. While cerebrospinal fluid and imaging biomarkers have shown links to physical decline, blood-based biomarkers offer a less invasive and more scalable alternative. However, their associations with physical performance across different stages of cognitive aging remain insufficiently explored. This study aimed to examine the cross-sectional associations between plasma amyloid beta 42 and total tau levels and physical function in older adults with normal cognition, motoric cognitive risk syndrome, and mild Alzheimer's disease.</div></div><div><h3>Methods</h3><div>A total of 159 community-dwelling older adults were enrolled and categorized into three cognitive groups. Plasma biomarker levels were measured using immunomagnetic reduction assays. Physical function was assessed using gait speed, Timed Up and Go, tandem stance, and dual-task walking. Generalized linear models were applied to assess associations between biomarkers and performance within each group.</div></div><div><h3>Results</h3><div>Higher plasma amyloid beta 42 levels were significantly associated with poorer Timed Up and Go performance in the full sample and in those with motoric cognitive risk syndrome. Unexpectedly, higher plasma total tau levels were positively associated with gait speed in the motoric cognitive risk group. No significant associations were observed for balance or dual-task performance.</div></div><div><h3>Conclusion</h3><div>Plasma biomarkers may reflect stage-specific mobility changes in aging populations. Their integration with performance-based tests may support early identification of functional decline and guide timely interventions.</div></div>","PeriodicalId":94003,"journal":{"name":"Experimental gerontology","volume":"212 ","pages":"Article 112975"},"PeriodicalIF":4.3,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145618066","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01DOI: 10.1016/j.exger.2025.112986
Yang Xu , Fei Jiang , Bin Zheng , Guang-Lei Zhang , Ren-Hu Li
Objectives
To quantify interactions between sleep duration and activities of daily living (ADL) limitations on low back pain (LBP) in Chinese adults ≥45 years using China Health and Retirement Longitudinal Study (CHARLS) data.
Methods
This study presents a cross-sectional analysis of CHARLS data collected between 2011 and 2015. Participants self-reported their sleep duration and LBP experiences. ADL limitations were assessed using a 12-item scale. Logistic regression analysis was used to evaluate the interaction effects of sleep duration and ADL limitations on LBP.
Results
Short sleep (OR = 1.50, 95 % CI 1.32, 1.70), basic activities of daily living (BADL) limitation (OR = 2.22, 95 % CI 1.68, 2.95), and instrumental activities of daily living (IADL) limitation (OR = 2.01, 95 % CI 1.72, 2.36) were independently associated with LBP. Multiplicative interactions were significant for short sleep with BADL (OR = 3.03, 95 % CI 1.97, 4.67) and IADL (OR = 1.94, 95 % CI 1.53, 2.45), and for long sleep with BADL (OR = 2.54, 95 % CI 1.41, 4.56) and IADL (OR = 1.62, 95 % CI 1.20, 2.18). Additive synergy was found in adults ≥60 years with short sleep and BADL (RERI = 2.81, AP = 0.56, S = 3.32), while long sleep and IADL showed antagonism (RERI = -1.30, AP = -0.68, S = 0.41).
Conclusion
In adults ≥60 years, short sleep combined with BADL limitation exhibits an additive interaction on LBP, while long sleep combined with IADL limitation shows antagonism. Therefore, longitudinal studies are needed for causality and targeted interventions.
{"title":"The interactive influences of sleep duration and activities of daily living on low back pain: Insights from CHARLS","authors":"Yang Xu , Fei Jiang , Bin Zheng , Guang-Lei Zhang , Ren-Hu Li","doi":"10.1016/j.exger.2025.112986","DOIUrl":"10.1016/j.exger.2025.112986","url":null,"abstract":"<div><h3>Objectives</h3><div>To quantify interactions between sleep duration and activities of daily living (ADL) limitations on low back pain (LBP) in Chinese adults ≥45 years using China Health and Retirement Longitudinal Study (CHARLS) data.</div></div><div><h3>Methods</h3><div>This study presents a cross-sectional analysis of CHARLS data collected between 2011 and 2015. Participants self-reported their sleep duration and LBP experiences. ADL limitations were assessed using a 12-item scale. Logistic regression analysis was used to evaluate the interaction effects of sleep duration and ADL limitations on LBP.</div></div><div><h3>Results</h3><div>Short sleep (OR = 1.50, 95 % CI 1.32, 1.70), basic activities of daily living (BADL) limitation (OR = 2.22, 95 % CI 1.68, 2.95), and instrumental activities of daily living (IADL) limitation (OR = 2.01, 95 % CI 1.72, 2.36) were independently associated with LBP. Multiplicative interactions were significant for short sleep with BADL (OR = 3.03, 95 % CI 1.97, 4.67) and IADL (OR = 1.94, 95 % CI 1.53, 2.45), and for long sleep with BADL (OR = 2.54, 95 % CI 1.41, 4.56) and IADL (OR = 1.62, 95 % CI 1.20, 2.18). Additive synergy was found in adults ≥60 years with short sleep and BADL (RERI = 2.81, AP = 0.56, S = 3.32), while long sleep and IADL showed antagonism (RERI = -1.30, AP = -0.68, S = 0.41).</div></div><div><h3>Conclusion</h3><div>In adults ≥60 years, short sleep combined with BADL limitation exhibits an additive interaction on LBP, while long sleep combined with IADL limitation shows antagonism. Therefore, longitudinal studies are needed for causality and targeted interventions.</div></div>","PeriodicalId":94003,"journal":{"name":"Experimental gerontology","volume":"213 ","pages":"Article 112986"},"PeriodicalIF":4.3,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145673262","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01DOI: 10.1016/j.exger.2025.112978
Laura Cianfruglia , Gretta Veronica Badillo Pazmay , Carlo Fortunato , Pietro Giorgio Spezia , Federica Novazzi , Francesco Piacenza , Marco Malavolta , Francesca Marchegiani , Rina Recchioni , Giulia Matacchione , Chiara Giordani , Maurizio Cardelli , Tiziana Casoli , Mirko Di Rosa , Antonio Cherubini , Giuseppe Pelliccioni , Riccardo Sarzani , Francesco Spannella , Fabrizia Lattanzio , Anna Rita Bonfigli , Robertina Giacconi
Torque teno virus (TTV) is a ubiquitous virus whose viremia increases in conditions of immune dysfunction and aging, suggesting its potential role as a biomarker of immunosenescence. This study investigated the association between TTV viremia and all-cause mortality risk over seven years in a hospitalized older cohort, and its relationship with inflammatory markers including osteopontin (OPN) and growth differentiation factor 15 (GDF15). Data from 956 patients were analyzed, with high TTV load defined as ≥5 log DNA copies/mL. High TTV viremia was significantly associated with increased mortality risk at 1, 3, and 7 years independently of age, sex, comorbidities, and inflammatory markers. In stratified analyses, this association was significant at one year in both males and females, but persisted at three and seven years only in males. The strongest association was observed in participants aged 80–89 years, remaining significant across all follow-up periods. When patients were stratified by a composite immune score reflecting degrees of immunosenescence, high TTV viremia predicted increased mortality among those with intermediate or severe immune dysfunction, persisting up to seven years in the most immunosenescent subgroup. Patients with elevated TTV loads exhibited increased erythrocyte sedimentation rate (ESR), decreased serum albumin and hemoglobin, and significantly higher plasma levels of OPN and GDF15, whereas IL-10 tended to decrease. No significant differences were observed for neutrophil-to-lymphocyte ratio, IL-6, CD163, CCL22, or CXCL9 between high and low TTV viremia groups. These findings indicate that high TTV viremia independently predicts mortality risk and reflects a pro-inflammatory and immunosenescent state.
{"title":"High Torque teno virus viremia predicts long-term mortality and reflects chronic low-grade inflammation (inflammaging) in geriatric inpatients","authors":"Laura Cianfruglia , Gretta Veronica Badillo Pazmay , Carlo Fortunato , Pietro Giorgio Spezia , Federica Novazzi , Francesco Piacenza , Marco Malavolta , Francesca Marchegiani , Rina Recchioni , Giulia Matacchione , Chiara Giordani , Maurizio Cardelli , Tiziana Casoli , Mirko Di Rosa , Antonio Cherubini , Giuseppe Pelliccioni , Riccardo Sarzani , Francesco Spannella , Fabrizia Lattanzio , Anna Rita Bonfigli , Robertina Giacconi","doi":"10.1016/j.exger.2025.112978","DOIUrl":"10.1016/j.exger.2025.112978","url":null,"abstract":"<div><div>Torque teno virus (TTV) is a ubiquitous virus whose viremia increases in conditions of immune dysfunction and aging, suggesting its potential role as a biomarker of immunosenescence. This study investigated the association between TTV viremia and all-cause mortality risk over seven years in a hospitalized older cohort, and its relationship with inflammatory markers including osteopontin (OPN) and growth differentiation factor 15 (GDF15). Data from 956 patients were analyzed, with high TTV load defined as ≥5 log DNA copies/mL. High TTV viremia was significantly associated with increased mortality risk at 1, 3, and 7 years independently of age, sex, comorbidities, and inflammatory markers. In stratified analyses, this association was significant at one year in both males and females, but persisted at three and seven years only in males. The strongest association was observed in participants aged 80–89 years, remaining significant across all follow-up periods. When patients were stratified by a composite immune score reflecting degrees of immunosenescence, high TTV viremia predicted increased mortality among those with intermediate or severe immune dysfunction, persisting up to seven years in the most immunosenescent subgroup. Patients with elevated TTV loads exhibited increased erythrocyte sedimentation rate (ESR), decreased serum albumin and hemoglobin, and significantly higher plasma levels of OPN and GDF15, whereas IL-10 tended to decrease. No significant differences were observed for neutrophil-to-lymphocyte ratio, IL-6, CD163, CCL22, or CXCL9 between high and low TTV viremia groups. These findings indicate that high TTV viremia independently predicts mortality risk and reflects a pro-inflammatory and immunosenescent state.</div></div>","PeriodicalId":94003,"journal":{"name":"Experimental gerontology","volume":"213 ","pages":"Article 112978"},"PeriodicalIF":4.3,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145673272","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01DOI: 10.1016/j.exger.2025.112972
Wanli Deng , Changqing Li , Xiaojiang Zhao
Background
The association between a single time-point measurement of sleep duration and sarcopenia has been extensively explored in existing literature. However, the potential link between sleep duration trajectories and sarcopenia remains largely unexplored. This study aims to assess the relationship between sleep duration trajectories and sarcopenia within a longitudinal cohort of middle-aged and older Chinese individuals.
Methods
This study analyzed a substantial cohort of participants (n = 6305), aged 45 to 80, drawn from the China Longitudinal Study of Health and Retirement (CHARLS). Sleep duration data, collected at intervals from 2011 to 2015, were employed to plot sleep duration trajectories using group-based trajectory modeling (GBTM). Sarcopenia was assessed utilizing data from 2015. Subsequently, a multivariable logistic regression model was applied to investigate the association between varying sleep duration trajectories and the risk of sarcopenia.
Results
Four distinct trajectories of sleep duration were identified: Class 1, characterized by persistently long sleep duration (n = 1391, 22.06 %); Class 2, characterized by persistently high-normal sleep duration (n = 2129, 33.77 %); Class 3, characterized by persistently low-normal sleep duration (n = 1401, 22.22 %); and Class 4, characterized by persistently short sleep duration (n = 1384, 21.95 %). In the model 0, both persistently long sleep duration (OR: 1.83, 95 % CI: 1.50–2.24; p < 0.001) and persistently short sleep duration (OR: 1.76, 95 % CI: 1.44–2.15; p < 0.001) were notably correlated with a greater risk of sarcopenia when compared to persistently high-normal sleep duration. Furthermore, the stratified analyses generally corroborated the primary findings.
Conclusions
Both persistently long and short sleep duration trajectories are associated with an elevated risk of sarcopenia, compared to persistently high-normal sleep duration trajectories among middle-aged and older Chinese adults. Furthermore, the findings highlight the essential need to monitor changes in sleep duration over time.
{"title":"Associations between sleep duration trajectories and sarcopenia among middle-aged and older Chinese adults","authors":"Wanli Deng , Changqing Li , Xiaojiang Zhao","doi":"10.1016/j.exger.2025.112972","DOIUrl":"10.1016/j.exger.2025.112972","url":null,"abstract":"<div><h3>Background</h3><div>The association between a single time-point measurement of sleep duration and sarcopenia has been extensively explored in existing literature. However, the potential link between sleep duration trajectories and sarcopenia remains largely unexplored. This study aims to assess the relationship between sleep duration trajectories and sarcopenia within a longitudinal cohort of middle-aged and older Chinese individuals.</div></div><div><h3>Methods</h3><div>This study analyzed a substantial cohort of participants (n = 6305), aged 45 to 80, drawn from the China Longitudinal Study of Health and Retirement (CHARLS). Sleep duration data, collected at intervals from 2011 to 2015, were employed to plot sleep duration trajectories using group-based trajectory modeling (GBTM). Sarcopenia was assessed utilizing data from 2015. Subsequently, a multivariable logistic regression model was applied to investigate the association between varying sleep duration trajectories and the risk of sarcopenia.</div></div><div><h3>Results</h3><div>Four distinct trajectories of sleep duration were identified: Class 1, characterized by persistently long sleep duration (n = 1391, 22.06 %); Class 2, characterized by persistently high-normal sleep duration (n = 2129, 33.77 %); Class 3, characterized by persistently low-normal sleep duration (n = 1401, 22.22 %); and Class 4, characterized by persistently short sleep duration (n = 1384, 21.95 %). In the model 0, both persistently long sleep duration (OR: 1.83, 95 % CI: 1.50–2.24; p < 0.001) and persistently short sleep duration (OR: 1.76, 95 % CI: 1.44–2.15; p < 0.001) were notably correlated with a greater risk of sarcopenia when compared to persistently high-normal sleep duration. Furthermore, the stratified analyses generally corroborated the primary findings.</div></div><div><h3>Conclusions</h3><div>Both persistently long and short sleep duration trajectories are associated with an elevated risk of sarcopenia, compared to persistently high-normal sleep duration trajectories among middle-aged and older Chinese adults. Furthermore, the findings highlight the essential need to monitor changes in sleep duration over time.</div></div>","PeriodicalId":94003,"journal":{"name":"Experimental gerontology","volume":"212 ","pages":"Article 112972"},"PeriodicalIF":4.3,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145590469","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}